Clinical Trial Update: A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS [Phase 2]

View source ↗

Summary

The Phase 2 pharmacokinetics and safety study of Augmentin ES-600 in children with community-acquired pneumonia and acute bacterial rhinosinusitis has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Rhinosinusitis
• Community-acquired Pneumonia

Drugs mentioned

• AUGMENTIN ES-600 (AMOXICILLIN AND CLAVULANATE POTASSIUM)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 2 | Status: WITHDRAWN